{"type":"rich","version":"1.0","title":"Postpardum Depression Drug Breakthrough, BlackRock’s Risky Software Bet, Tiffany Earnings","author_name":"Bloomberg Businessweek","author_url":"https://bloomberg.com/podcasts/advantage","provider_name":"Omny Studio","provider_url":"https://omny.fm","html":"<iframe src=\"https://omny.fm/shows/bloomberg-businessweek/postpardum-depression-drug-breakthrough-blackrock/embed\" width=\"100%\" height=\"180\" allow=\"autoplay; clipboard-write; fullscreen\" allowfullscreen frameborder=\"0\" title=\"Postpardum Depression Drug Breakthrough, BlackRock’s Risky Software Bet, Tiffany Earnings\"></iframe>","width":600,"height":180}